Acute inhibition of GIPR using neutralizing antibodies has shown the ability to substantially reduce body weight and improve obesity by enhancing the effectiveness of leptin [231, 235, 244, 245]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.